Supplemental Figure 3 from Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with ≪i>egfr</i>-Mutant Lung Cancers
openalex（2023）
摘要
pre-EGFR-TKI TMB by TP53 co-mutation and incidence of TP53 co-mutation by tertile (low/intermediate vs high)
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要